Edition:
United Kingdom

Advaxis Inc (ADXS.OQ)

ADXS.OQ on NASDAQ Stock Exchange Global Select Market

3.48USD
22 Apr 2019
Change (% chg)

$0.17 (+5.14%)
Prev Close
$3.31
Open
$3.34
Day's High
$3.56
Day's Low
$3.31
Volume
66,144
Avg. Vol
70,377
52-wk High
$30.60
52-wk Low
$2.72

About

Advaxis, Inc. is a clinical-stage biotechnology company focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant... (more)

Overall

Beta: 2.03
Market Cap(Mil.): $187.67
Shares Outstanding(Mil.): 41.07
Dividend: --
Yield (%): --

Financials

  ADXS.OQ Industry Sector
P/E (TTM): -- 69.30 32.55
EPS (TTM): -2.29 -- --
ROI: -105.74 8.91 13.83
ROE: -116.33 10.06 15.25

Earnings vs. Estimates